Trials / Sponsors / Kiniksa Pharmaceuticals International, plc
Kiniksa Pharmaceuticals International, plc
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Transition to KPL-387 Monotherapy Dosing & Administration Study Recurrent Pericarditis, Heart Diseases, Pericarditis | Phase 2 | 2026-03-25 |
| Recruiting | Phase 2/3 Study of KPL-387 in Recurrent Pericarditis Pericarditis, Pericarditis Acute, Recurrent Pericarditis | Phase 2 / Phase 3 | 2025-07-25 |
| Terminated | A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease Sjögrens Disease | Phase 2 | 2024-07-17 |
| Active Not Recruiting | REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients Recurrent Pericarditis | — | 2021-03-16 |
| Completed | Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) COVID | Phase 2 / Phase 3 | 2020-07-28 |